Navigation Links
UCLA/VA partners with ASU to advance biosensor technology for urinary tract infections
Date:9/12/2007

ction is the most common urological disease in the United States and the most common bacterial infection of any organ system. It is a major cause of patient death and health care expenditures for all age groups, accounting for more than 7 million office visits and more than 1 million hospital admissions per year. Catheter associated urinary tract infection accounts for 40 percent of all hospital-acquired infections more than 1 million cases each year. The total cost of urinary tract infections to the U.S. health care system in 2000 was approximately $3.5 billion.

The grant is funded by the National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health.

For more than 50 years, the UCLA Department of Urology has continued to break new ground and set the standards of care for patients suffering from urological conditions. In collaboration with UCLAs eminent research scientists, the departments internationally acclaimed physicians have pioneered treatments for many conditions, including cancers of the prostate, bladder and kidney; kidney stones; pelvic floor disorders; genitourinary tract conditions; incontinence; and sexual dysfunction in men and women.

The Biodesign Institute at Arizona State University is focused on innovations that improve heath care; provide renewable sources of energy and clean our environment; outpace the global threat of infectious disease; and enhance national security. Using a team approach that converges the biosciences with nanoscale engineering and advanced computing, the institute aims to find solutions to complex global challenges and accelerate these discoveries to market. The institute also educates future scientists by providing hands-on laboratory research for more than 250 students each semester.

GeneFluidics was founded in 2000 by Vincent Gau, who received his doctorate in biomedical engineering from UCLA. GeneFluidics goal is to develop a fast, acc
'/>"/>

Contact: Amy Albin
aalbin@mednet.ucla.edu
310-794-8672
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
2. New study: Sexually transmitted disease treatment can be effectively administered by sex partners
3. Molecular Partners Required For Appropriate Neuronal Gene Repression
4. New partnership to clear landmines for African Elephants
5. UC San Diego partners with Venter Institute to build marine microbial genomics cyberinfrastructure
6. Gut microbes partnership helps body extract energy from food, store it as fat
7. Research advances quest for HIV-1 vaccine
8. Inexpensive, mass-produced genes core of synthetic biology advances at UH
9. Study of genomic DNA leads to new advances in cancer diagnostics
10. Applied Biosystems Introduces Advanced Gene Expression Service Provider Program
11. Molecular models advance the fight against malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... selection for traits that are attractive to the opposite ... to mate, the tail of male peacocks being an ... Riverside have now found that sexual selection and "placentation" ... Describing the life histories of more than 150 species ... that species with placentas tend to have males that ...
(Date:7/9/2014)... A crucial piece of the puzzle behind nature,s ... that could help advance the development of artificial ... been provided by an international collaboration of scientists ... Laboratory (Berkeley Lab) and the SLAC National Accelerator ... Light Source (LCLS), the world,s most powerful x-ray ...
(Date:7/9/2014)... Researchers studying critically ill children with traumatic injuries ... patients are likely to develop a hospital-acquired infection. ... Hospital and published online in June in the ... larger efforts that could lead to the clinical ... to prevent or reverse immune system damage following ...
Breaking Biology News(10 mins):Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4Postcards from the photosynthetic edge 2Postcards from the photosynthetic edge 3Immune function predicts infection risk among child trauma patients 2Immune function predicts infection risk among child trauma patients 3
... the ozone hole that forms annually over Antarctica and ... yet caused a recovery of the ozone hole. ... limited human emissions of ozone-depleting substances, satellites have monitored ... it essentially stabilize, ceasing to grow substantially larger. However, ...
... study of older mice, wolfberries appear to interact with the ... The research, led by scientists at the Jean Mayer USDA ... University, suggests the wolfberry may increase the activity of dendritic ... the immune system to defend against viral infections. The results ...
... ghosts, are among the most elusive and highly prized ... Bahamas and similar tropical habitats around the world. Bonefish ... annually, but this fishery is threatened in many areas ... are scrambling to identify and protect critical habitats and ...
Cached Biology News:NASA reveals new results from inside the ozone hole 2NASA reveals new results from inside the ozone hole 3Older mice fed wolfberries show reduced risk for flu virus with vaccine 2University researchers observe surprising bonefish spawning behavior in the Bahamas 2University researchers observe surprising bonefish spawning behavior in the Bahamas 3
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational research ... Alliqua is an emerging biomedical company acquiring, developing, manufacturing, ... market. , Free report download: http://equitiesiq.com/reports/alliqua/ , ... management team and Board, which launched the company’s new ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 In recent ... motives and methods in product development and promotion has ... industry. This mistrust, fueled by concerns about the insidious ... by reports of spectacular fines to the world’s biggest ...
(Date:1/14/2014)... January 13, 2014 Bob Hainsey, a ... than 20 years in the industry, has joined ... Hainsey will serve as the society’s Science and Technology ... join SPIE as our Technology Strategist, further strengthening the ...
(Date:1/14/2014)... Park, NC (PRWEB) January 14, 2014 ... focusing on ultra-sensitive POC diagnostic platforms and novel disease specific ... first round of financing netting a total of $690,000. The ... equity capital in the company. This group of private investors ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2BioMedomics, Inc. Closes $690K Round of Financing 2
... Yongye Biotechnology,International, Inc. (OTC Bulletin Board: YGYB) ("Yongye" ... of nutrients for plants and,animals in the People,s ... a conference call at 8:00 a.m. Eastern Time ... the quarter ended June 30, 2008., To ...
... Massachusetts, August 13, Shire Limited (LSE: SHP, NASDAQ: ... since July,3, 2008 it has acquired 81% of ... indirect subsidiary Shire Deutschland Investments GmbH (formerly Maia,Elfte ... respect of the remaining outstanding shares in Jerini., ...
... Finn, Jr.,C.P.A. ("Finn"), Assignee of the assets of Spherics, ... all pharmaceutical,intellectual property will be sold at a sealed ... pieces of intellectual property for sale is its lead,product, ... currently has,more than $2 billion in sales despite twice ...
Cached Biology Technology:Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results 2Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document 2Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document 3